PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#Ibandronate Sodium ×

UPDATED
Actualizaciones regulatorias
4 sept 2026•1 min de lectura
FDA Approves ANDA078948 for Ibandronate Sodium Tablet
The FDA has approved ANDA078948 for a prescription oral tablet of Ibandronate Sodium 150 mg, sponsored by Apotex and manufactured by Golden State Medical Supply.